Our Pricing

Buy Wegovy UK - All Doses In Stock & Ready to Ship

Published on: June 03, 2026

When you buy Wegovy UK online pharmacy treatments, stock availability matters. At Cured Pharmacy, all Wegovy doses are in stock and ready to ship, with transparent pricing from £79.00 and a free clinical assessment by UK-registered prescribers that takes under 3 minutes to complete.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics the natural GLP-1 hormone, which regulates appetite signals in the brain and slows gastric emptying, helping you feel fuller for longer after meals.

In the landmark STEP 1 clinical trial, adults using Wegovy alongside lifestyle interventions achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results represent one of the most significant weight loss outcomes seen in pharmacological obesity treatment trials to date.

Wegovy is administered as a once-weekly subcutaneous injection, starting at a low dose of 0.25 mg and gradually increasing over 16-20 weeks to the maintenance dose of 2.4 mg. This dose escalation schedule helps minimise gastrointestinal side effects whilst allowing your body to adjust to the medication [2].

Wegovy Dosing Schedule and What to Expect

Your Wegovy treatment follows a structured dose escalation protocol designed to optimise tolerability. You'll begin with 0.25 mg weekly for four weeks, then progress through 0.5 mg, 1.0 mg, and 1.7 mg doses before reaching the full maintenance dose of 2.4 mg [2].

Most patients notice reduced appetite within the first two weeks of treatment, though significant weight loss typically becomes evident after 8-12 weeks at therapeutic doses. Clinical data shows that patients who remain on treatment for the full 68-week study period achieve substantially greater weight reduction than those who discontinue early [1].

Each Wegovy pen is pre-filled for single use and contains four doses, making the injection process straightforward. Your UK prescriber will provide full administration guidance during your consultation, and all pens come with detailed patient information leaflets approved by the MHRA.

Managing Common Side Effects

The most frequently reported side effects are gastrointestinal: nausea, diarrhoea, vomiting, and constipation, typically occurring during dose escalation phases [2]. These effects are generally mild to moderate and diminish as your body adapts to the medication. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these symptoms effectively.

Wegovy vs Mounjaro: Comparing GLP-1 Weight Loss Treatments

Both Wegovy and Mounjaro are injectable weight loss medications licensed in the UK, but they work through different receptor mechanisms. Wegovy contains semaglutide, a single GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist available for weight management.

Head-to-head clinical data suggests tirzepatide may produce slightly greater weight reduction in some patients, with the highest dose achieving an average 22.5% body weight loss in the SURPASS-3 trial [3]. However, Wegovy remains highly effective, with proven cardiovascular benefits demonstrated in the SELECT trial, showing a 20% reduction in major adverse cardiovascular events [4].

Your choice between these treatments depends on multiple factors including your medical history, treatment goals, tolerability profile, and prescriber recommendation. Both require ongoing lifestyle modifications including reduced-calorie diet and increased physical activity to achieve optimal results.

Which Treatment Suits Your Needs?

A UK prescriber will assess your BMI, existing health conditions, previous weight loss attempts, and any contraindications before recommending the most appropriate treatment. Patients with established cardiovascular disease may particularly benefit from Wegovy given its proven cardioprotective effects, whilst those seeking maximum weight reduction may be considered for alternative options subject to clinical suitability [4].

Why Wegovy Stock Availability Matters in the UK

Wegovy has experienced significant supply constraints across UK pharmacies since its launch, with many patients facing treatment interruptions that can compromise weight loss outcomes. Maintaining consistent weekly dosing is essential for achieving the results seen in clinical trials, as treatment gaps can lead to weight regain and require dose re-escalation.

At Cured Pharmacy, we maintain stock of all Wegovy doses from the initial 0.25 mg starter pens through to the 2.4 mg maintenance dose. This ensures you can progress through your dose escalation schedule without delays and continue your treatment plan without interruption, which is critical for both efficacy and safety.

When you complete your free online consultation with our UK-registered prescribers, you'll receive confirmation of stock availability before any payment is processed. We never take payment for out-of-stock medications, and our transparent pricing model shows you the exact cost upfront, with no hidden fees or surprise charges at checkout.

How to Buy Wegovy UK from Cured Pharmacy

Purchasing Wegovy through Cured Pharmacy is straightforward and fully compliant with UK medicines regulations. Start by completing our free online clinical assessment, which takes under 3 minutes and covers your medical history, current medications, and weight management goals. This assessment is reviewed by a UK-registered prescriber, not an algorithm.

If Wegovy is deemed clinically appropriate for you, your prescription is issued electronically and sent directly to our dispensing team. All Wegovy pens are sourced from UK-licensed wholesalers and dispensed by our GPhC-registered pharmacy (registration number 9012511) under the supervision of our superintendent pharmacist, Tarun Kumar (GPhC 2233073).

Your medication is dispatched in 100% discreet packaging with no external branding or indication of contents. We offer next-day delivery options across the UK, and you'll receive tracking information once your order ships. Every prescription includes comprehensive patient information and access to our clinical team for ongoing support throughout your treatment journey.

Transparent Pricing and Clinical Support

Wegovy pricing at Cured Pharmacy starts from £79.00, with the exact cost depending on your prescribed dose. Unlike some online services, we display all prices before you complete your consultation, so there are no unexpected costs. Our lowest price guarantee ensures you're getting competitive UK pricing without compromising on pharmaceutical quality or clinical care standards.

Who Can Use Wegovy and Important Safety Information

Wegovy is licensed for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. It is not suitable for everyone, and certain medical conditions may preclude its use.

You should not use Wegovy if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, as semaglutide has been associated with thyroid C-cell tumours in animal studies [2]. Wegovy is also contraindicated in pregnancy, and effective contraception is recommended for women of childbearing potential during treatment.

Common contraindications include severe gastrointestinal disease, diabetic retinopathy requiring active treatment, and previous severe hypersensitivity reactions to semaglutide or any excipients. Your UK prescriber will conduct a thorough assessment of your medical history to ensure Wegovy is safe and appropriate for your individual circumstances before issuing a prescription.

Regular monitoring is recommended during Wegovy treatment, particularly in the first few months. You should contact your prescriber if you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or changes in vision. All prescription medications carry risks alongside benefits, and ongoing clinical oversight ensures you achieve optimal outcomes whilst minimising potential adverse effects.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Lincoff, A. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.